Drug Shortage Report for DOCETAXEL INJECTION USP

Last updated on 2019-12-02 History
Report ID 98444
Drug Identification Number 02361957
Brand name DOCETAXEL INJECTION USP
Common or Proper name Docetaxel Injection USP
Company Name PFIZER CANADA ULC
Active Ingredient(s) DOCETAXEL
Strength(s) 10.0MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 8mL vial
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-11
Estimated end date 2019-12-18
Actual end date
Shortage status Actual shortage
Updated date 2019-12-02
Company comments Other presentations remain available.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-11-11 English Compare
v2 2019-11-11 French Compare
v3 2019-11-12 English Compare
v4 2019-12-02 English Compare
v5 2019-12-02 French Compare